Printer friendly page
Asian Producers Raise Their Profiles In the Global Pharmaceutical Value Chain
May 2, 2006
By: Patricia Van Arnum
Indian and Chinese manufacturers are becoming a force in the global pharmaceutical supply chain by further penetrating Western generic drug markets, upping investments in manufacturing active pharmaceutical ingredients (APIs) and in formulations, and strengthening internal research and development.
"Indian companies are becoming leaders in capital investments in generics and are leading in drug master files (DMFs)," says Cynthia Dowd Greene, vice-president for industry research at Newport Strategies (Portland, ME, www.newportstrategies.com/), who recently spoke at the Generic Pharmaceutical Association's (GPhA, Arlington, VA, www.gphaonline.org/) API 2006 Meeting. In 2005, Indian companies filed 265 DMFs, up from 227 in 2004 and 139 in 2003, notes Greene.
View Full Article